VAL (VAL)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 6/9, Altman Z 3.5. DCF fair value of $35 implies 65% downside based on model assumptions. Beneish M-Score of -2.20 exceeds the -2.22 academic threshold — earnings quality may warrant further review.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe company exhibits a highly efficient capital structure with an ROIC-WACC spread of +0.7%, indicating value creation that narrowly exceeds the cost of capital, yet this margin is modest relative to high-quality peers. The DuPont decomposition reveals that the impressive 31.0% ROE is driven almost exclusively by exceptional net margins at 41.5%, while asset turnover remains constrained at 0.45x and leverage sits at a conservative 1.67x; this suggests profitability relies on pricing power or niche product mix rather than operational velocity or financial engineering. Credit metrics reinforce stability, with an Altman Z-Score of 3.6 signaling low bankruptcy risk and a Beneish M-Score of -2.20 suggesting earnings are likely authentic, supported by a solid Piotroski F-Score of 6/9 despite flat revenue growth of just 0.3% year-over-year.
Valuation metrics present a stark divergence between current market pricing and intrinsic value estimates derived from discounted cash flow analysis. Trading at a P/E multiple of 7.0x, the stock appears significantly cheaper than its historical trajectory and likely below sector averages given the high margin profile, yet the DCF model assigns a fair value that implies substantial downside relative to recent trading levels. The negative 65.6% gap between current price and the $34 fair value suggests the market is pricing in persistent stagnation or expects future growth rates far lower than the implied 17.2% free cash flow expansion rate over the next decade, creating a potential disconnect between fundamental earnings power and investor sentiment regarding forward momentum.
Risk assessment remains neutral with no insider buying activity observed over the last 90 days, which typically signals an absence of management confidence in immediate near-term catalysts despite the company's strong balance sheet characteristics. The combination of stagnant top-line growth and a valuation gap that implies significant downside potential creates a scenario where capital appreciation may be constrained unless revenue dynamics shift or multiple compression reverses; conversely, the high margin environment offers a defensive floor if macroeconomic conditions deteriorate. Investors must weigh whether the current discount reflects temporary market overreaction to zero growth or a structural inability of management to scale operations beyond its current niche footprint.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
Interactive5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.
The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 0% YoY revenue.
Sensitivity Matrix
| TG ↓ / WACC → | 8.3% | 10.3% | 12.3% |
|---|---|---|---|
| 2% | $43 | $31 | $23 |
| 3% | $50 | $35 | $26 |
| 4% | $61 | $40 | $28 |
Center = base case. Green = >10% upside, Red = >10% downside vs $92.73.
Pre-computed DCF: WACC=10.3%, terminal growth 3%. Fair value $35 (-65.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Risk Profile
Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XES or MDYG, the fund manager is mechanically forced to buy or sell VAL shares regardless of VAL's individual fundamentals. We estimate $1.1B of passive capital is structurally linked to VAL through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in VAL to visualize passive redemption contagion across ETFs and collateral stocks.
If VAL (VAL) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Exxon Mobil Corp. (XOM) as the most exposed collateral stock, sharing 1 ETFs with VAL. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 17 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
VAL Ownership Dynamics
Passive funds hold 1 in every 5 VAL shares, reducing daily market volatility.
VAL (VAL) exerts notable gravity on the passive index market, currently representing 3.8% of the XES (XES) and 0.4% of the MDYG (MDYG). Across 18 tracked ETFs, approximately 13M shares (19.3% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.
ETFs with Highest VAL Exposure
Float lock-up computed from 18 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
VAL Institutional Volume Profile
252-day volume distribution by price level. The Point of Control (POC) marks — the price where the most institutional volume transacted — an implicit support/resistance floor.
The highest-volume price zone for VAL over the past year sits near $51.15 (19% of 252-day volume). The current price of $92.73 trades 81.3% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target. The highly concentrated volume profile (19% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.
Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.
VAL Capital Efficiency
How efficiently does VAL convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
VAL converts 25% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 75% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 0.9% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-13 | 489 | $97.20 | $47,530.8 |
| 2026-05-07 | 10 | $92.80 | $928 |
| 2026-05-06 | 94,872 | $92.81 | $8.8M |
| 2026-05-05 | 3,426 | $102.52 | $351,233.52 |
| 2026-05-04 | 115 | $102.23 | $11,756.45 |
| 2026-05-01 | 41,500 | $101.98 | $4.2M |
| 2026-04-30 | 71 | $103.98 | $7,382.58 |
| 2026-04-28 | 6,878 | $97.35 | $669,573.3 |
| 2026-04-27 | 29 | $91.19 | $2,644.51 |
| 2026-04-23 | 107 | $90.46 | $9,679.22 |
| 2026-04-20 | 1,423 | $88.56 | $126,020.88 |
| 2026-04-15 | 48 | $92.01 | $4,416.48 |
| 2026-04-13 | 28,024 | $97.59 | $2.7M |
| 2026-04-09 | 273 | $99.97 | $27,291.81 |
| 2026-04-07 | 796 | $97.44 | $77,562.24 |
| 2026-04-06 | 587 | $98.04 | $57,549.48 |
| 2026-04-02 | 369 | $96.38 | $35,564.22 |
| 2026-03-27 | 6,250 | $101.94 | $637,125 |
| 2026-03-23 | 15 | $92.52 | $1,387.8 |
| 2026-03-20 | 100 | $95.68 | $9,568 |
| 2026-03-17 | 20 | $91.54 | $1,830.8 |
| 2026-03-13 | 204 | $92.80 | $18,931.2 |
| 2026-03-11 | 1,400 | $91.09 | $127,526 |
| 2026-03-10 | 1,656 | $90.81 | $150,381.36 |
| 2026-03-05 | 2,142 | $94.44 | $202,290.48 |
| 2026-02-27 | 1 | $94.55 | $94.55 |
| 2026-02-23 | 3,300 | $95.75 | $315,975 |
| 2026-02-20 | 105 | $92.49 | $9,711.45 |
| 2026-02-13 | 60 | $88.89 | $5,333.4 |
| 2026-02-11 | 936 | $79.81 | $74,702.16 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Price Correlations
Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.
| Peer | 252-Day (1Y) | 126-Day (6M) | Direction |
|---|---|---|---|
| WTGXX | NaN | NaN | |
| NE | 0.782 | 0.757 | High co-movement |
| RIG | 0.718 | 0.732 | High co-movement |
| SDRL | 0.643 | 0.524 | Moderate |
| NOV | 0.561 | 0.477 | Moderate |
| TDW | 0.524 | 0.447 | Moderate |
| PTEN | 0.523 | 0.406 | Moderate |
| MUR | 0.502 | 0.366 | Moderate |
| HP | 0.498 | 0.427 | Moderate |
| SLB | 0.480 | 0.341 | Moderate |
Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.
Compare VAL to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.